Comparison
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 vs 3q13 Microdeletion Syndrome C2931338
Clinical comparison between 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome and 3q13 Microdeletion Syndrome for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
A severe mitochondrial disorder affecting the brain, hearing, and energy metabolism. It causes progressive neurological decline, hearing loss, and metabolic problems. Management requires intensive supportive care.
3q13 Microdeletion Syndrome C2931338
A genetic disorder from missing material on chromosome 3q13, associated with developmental delays, intellectual disability, and various congenital features.
6 comparison axes
Onset
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
0-5
3q13 Microdeletion Syndrome C2931338
Variable
Onset patterns differ
Severity
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
severe
3q13 Microdeletion Syndrome C2931338
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
Chronic
3q13 Microdeletion Syndrome C2931338
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
No
3q13 Microdeletion Syndrome C2931338
No
Different transmission
Body System
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
metabolic
3q13 Microdeletion Syndrome C2931338
congenital
Same/different system
Category
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
metabolic
3q13 Microdeletion Syndrome C2931338
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-with-deafness-encephalopathy-and-leigh-like-syndrome-C4040739 and 3q13-microdeletion-syndrome-C2931338 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 | 3q13 Microdeletion Syndrome C2931338 | Discriminating power |
|---|---|---|---|
| Neurologic course | Progressive encephalopathy and neurologic decline may occur. | Developmental delay or intellectual disability is more typical; progression is not established. | Moderate |
| Hearing | Hearing loss is a described core feature. | Hearing loss is not established from the supplied description. | Moderate |
| Metabolic features | Energy-metabolism problems and abnormal organic-acid findings may occur. | A primary metabolic presentation is not established. | High |
When to favor each condition
Choose 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 when
Early progressive encephalopathy with hearing loss
This combination fits the described mitochondrial phenotype better than isolated developmental delay.
Moderate
Suspected energy-metabolism disorder
Metabolic abnormalities point toward the left condition, but results are not diagnostic alone.
Moderate
Leigh-like brain involvement
A Leigh-like pattern supports consideration of the left diagnosis after specialist review.
Low
Choose 3q13 Microdeletion Syndrome C2931338 when
Congenital developmental disorder without metabolic crisis
Developmental delay and congenital features better match the microdeletion description.
Moderate
Chromosomal copy-number abnormality
A confirmed 3q13 deletion supports the right diagnosis.
High
Stable intellectual disability
A nonprogressive congenital course is more consistent with the right condition, though overlap is possible.
Low
How key tests differ
| Test | 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 | 3q13 Microdeletion Syndrome C2931338 | Interpretation |
|---|---|---|---|
| Urine organic acids | May show elevated 3-methylglutaconic acid; no cutoff is supplied. | No characteristic organic-acid abnormality is established. | An abnormal result suggests a metabolic disorder but does not alone confirm the diagnosis. |
| Genetic or genomic testing | A mitochondrial or related gene finding may be sought by specialists. | Chromosomal microarray may identify a 3q13 deletion. | Test choice depends on phenotype; confirmation requires qualified interpretation. |
| Neuroimaging and hearing assessment | May show Leigh-like changes and hearing impairment. | Findings are variable and not specifically established here. | Imaging and audiology support evaluation but are not definitive by themselves. |
Prognosis comparison
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
- Outcome
- A severe, progressive course is described, but exact survival cannot be stated from these data.
- Factors
- Neurologic progression, metabolic instability, and hearing or feeding needs may influence outcome.
3q13 Microdeletion Syndrome C2931338
- Outcome
- Generally described as moderate, with variable developmental and congenital effects.
- Factors
- Extent of the deletion, associated anomalies, and available supports may affect outcome.
Time frame: Both are chronic; meaningful numerical prognosis is not established here.
Phenotype, confirmed genetic result, complications, and access to supportive care.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic deterioration | Progressive decline is described and may be severe. Intellectual disability may occur; progressive decline is not established. Individual course varies and needs specialist monitoring. |
| Hearing impairment | Hearing loss is a recognized feature. Not established from the supplied source. Formal audiology is appropriate when clinically indicated. |
| Developmental and congenital burden | Neurologic disease may impair development. Developmental delay, intellectual disability, and congenital features are described. Support needs differ and should be individualized. |
Patient education highlights
- HighDiagnosis versus test result
An abnormal laboratory or imaging finding is not automatically a diagnosis and needs clinician review.
- HighUrgent changes
New seizures, breathing difficulty, reduced alertness, or feeding failure require urgent medical care.
- MediumLong-term support
Both conditions may need developmental, neurologic, hearing, and family support tailored to the child.